Creative Medical Technology EPS CELZ
Diluted earnings per share by quarter and over the last twelve months, from 2010.
- Last 12 months, to Jun 30, 2026
- −$1.97
- Latest quarter, Q2 FY26
- −$0.41
- Fiscal year 2025
- −$2.49
Creative Medical Technology's earnings per share was −$1.97 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was −$0.41.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$2.49 | n/a |
| FY2024 | −$2.22 | n/a |
| FY2023 | −$3.76 | n/a |
| FY2022 | −$8.92 | −111% |
| FY2021 | $80.60 | n/a |
| FY2019 | −$2100.00 | n/a |
| FY2018 | −$37500.00 | n/a |
| FY2017 | −$15000.00 | n/a |
| FY2016 | $0.00 | n/a |
| FY2015 | $0.00 | n/a |
| FY2014 | $0.00 | n/a |
| FY2013 | $0.00 | n/a |
| FY2012 | $0.00 | n/a |
| FY2011 | $0.00 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$0.41 | n/a | −$1.97 | |
| Q1 FY26 | −$0.38 | n/a | −$2.04 | |
| Q4 FY25 | −$0.70 | n/a | −$2.49 | |
| Q3 FY25 | −$0.48 | n/a | −$2.88 | |
| Q2 FY25 | −$0.48 | n/a | −$3.15 | |
| Q1 FY25 | −$0.83 | −214% | −$3.78 | |
| Q4 FY24 | −$1.09 | n/a | −$2.22 | |
| Q3 FY24 | −$0.75 | n/a | −$2.34 | |
| Q2 FY24 | −$1.11 | n/a | −$2.61 | |
| Q1 FY24 | $0.73 | n/a | −$2.28 | |
| Q4 FY23 | −$1.21 | n/a | −$3.76 | |
| Q3 FY23 | −$1.02 | n/a | −$6.97 |
Against its peers
Companies in Healthcare nearest Creative Medical Technology's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| CELZCreative Medical Technology | −$1.97 | |
| OXBROXBRIDGE RE HOLDINGS | $0.02 | |
| EDUCEducational Development | $0.19 | |
| GTIMGood Times Restaurants | $0.21 | +75% a year |
| MDRRMedalist Diversified | $3.84 | |
| BCGBinah Capital | $0.16 | |
| VIPVulcan Infrastructure & Power | $0.07 | |
| MXCMexco Energy | $0.75 | −5% a year |
| CKXCKX Lands | $1.42 | +647% a year |
| MSGMMotorsport Games | $0.43 | +187% a year |
| ATCHAtlasClear | $0.01 | |
| Peer median | $0.20 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Creative Medical Technology
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.